Health By Matthew Herper and Helen Branswell FDA advisory panel votes unanimously that Pfizer and Moderna shots be authorized for young children
Health By Helen Branswell and Matthew Herper Tracking an FDA advisory panel meeting on Covid vaccines in young children
Pharmalot By Ed Silverman Simmering disputes persist as Covid patent waiver talks come down to the wire
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Health By Kate Sheridan Homeless and incarcerated people in Minnesota struggled to access Covid vaccines
The Readout LOUD By Adam Feuerstein and Meg Tirrell An emergency doctor and parent sorts through Covid vaccine options for kids under 5
Special Report By STAT Staff Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
Pharmalot By Ed Silverman WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy
Health By Matthew Herper FDA authorizes Pfizer and Moderna Covid vaccines for infants, toddlers, and preschoolers
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Paul Offit on Covid vaccines for kids, plus: how the Fed affects biotech, & another Alzheimer’s setback
First Opinion By Steve Brozak and Richard Marfuggi Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers
Pharmalot By Ed Silverman Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire
First Opinion By Thomas B. Cueni Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity
Pharmalot By Ed Silverman Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results
First Opinion By Muhammad Yunus Preparing for the next pandemic: Time to follow a social business model for patent-free global medicine production
The Readout LOUD By Adam Feuerstein and Meg Tirrell Listen: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Health By Helen Branswell Pfizer/BioNTech to seek Covid vaccine authorization for children under age 5
Pharmalot By Ed Silverman Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
Health By Matthew Herper CDC recommends Covid boosters for kids ages 5 to 11 after advisory committee vote
Health By Elizabeth Cooney Large U.K. study links vaccination after Covid infection to lower odds of long Covid symptoms
Health By Lauran Neergaard — Associated Press FDA clears Covid booster shot for healthy kids ages 5 to 11
Pharmalot By Ed Silverman National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program
Politics By Lev Facher Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?
Pharmalot By Ed Silverman Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic
Pharmalot By Ed Silverman A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
First Opinion By Els Torreele Global health should not be determined by pharma investors and shareholders